Frequently Asked Questions
The market is segmented based on Segmentation, By Dermatological Diseases (Acne, Dermatitis, Psoriasis, Skin Cancer, Others), Prescription mode (Prescription Based Drugs, Over Counter Drugs), Drug Classification (Corticosteroids, Astringents, Anti-Inflammatory & Antipruritic Drugs, Anti-Infective/Antibacterial Drugs, Antifungal Drugs), Route Of Administration (Topical, Oral, Parenteral Administration), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Speciality Clinics, Cosmetic Centres) – Industry Trends and Forecast to 2031.
.
The Global Dermatology Drugs Market size was valued at USD 20.79 USD Billion in 2021.
The Global Dermatology Drugs Market is projected to grow at a CAGR of 10.25% during the forecast period of 2022 to 2031.
The major players operating in the market include LUPIN, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer , Sanofi, Amgen , Lilly, AstraZeneca, AbbVie , Johnson & Johnson Private Limited, LEO Pharma A/S, Merck & Co. , Bausch Health Companies , Bristol-Myers Squibb Company .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
